Department of Operative Dentistry, HITEC-IMS Dental College
Rawalpindi, Punjab Province, Pakistan
Location status: Recruiting
Location contact
Beenish Qureshi, BDS, FCPS
CONTACT
Monal Fatima, BDS
CONTACT
NCT Number: NCT07410780
This study is designed to find out how different root canal sealers affect pain after root canal treatment. We are comparing two types of dental sealers: bioceramic sealer and calcium hydroxide sealer.
Participants who need root canal treatment will receive one of these sealers as part of their standard dental care. After the procedure, they will be asked to report any pain they experience for a few days.
The information from this study will help dentists choose sealers that may reduce post-treatment pain and improve patient comfort after root canal therapy.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Rawalpindi, Punjab Province, Pakistan
Location status: Recruiting
Beenish Qureshi, BDS, FCPS
CONTACT
Monal Fatima, BDS
CONTACT
This randomized controlled clinical trial is designed to evaluate postoperative pain following root canal obturation using two different endodontic sealers: a bioceramic (calcium silicate-based) sealer and a calcium hydroxide-based sealer. Postoperative pain is a common complication of root canal therapy and may influence patient satisfaction as well as perceived treatment success. The physical and chemical properties of root canal sealers may contribute to postoperative discomfort through their interaction with periapical tissues.
The study will be conducted at the Department of Operative Dentistry, HITEC-IMS Dental College over a period of six months to 1 year following institutional approval. A total sample size of 50 participants will be enrolled and randomly allocated into two parallel groups using a lottery method, with 25 participants assigned to each group. A single-blind design will be maintained, in which participants will be unaware of the sealer used.
All clinical procedures will be performed in a single visit by the same operator to minimize procedural variability. Following diagnosis and confirmation of pulp vitality, standard endodontic treatment will be carried out under local anesthesia and rubber dam isolation. Canal preparation will be performed using hand and nickel-titanium rotary instruments. Irrigation will be carried out using sodium hypochlorite and EDTA solutions, followed by saline as the final rinse. Canals will be dried using sterile paper points.
Obturation will be performed using a single-cone technique with a matching-taper gutta-percha cone coated with the assigned sealer. Participants in the experimental groups will receive either a bioceramic sealer or a calcium hydroxide-based sealer. Access cavities will be restored with glass ionomer cement, and occlusal reduction will be performed to minimize postoperative discomfort due to occlusal trauma. No postoperative medications will be prescribed.
Postoperative pain will be evaluated using a Visual Analog Scale (VAS) at predefined time intervals following obturation. Analgesic intake, if any, will also be recorded to support accurate interpretation of pain outcomes.
Collected data will be entered into a spreadsheet and analyzed using statistical software. Comparative analysis of postoperative pain scores between the two groups at different time intervals will be performed using appropriate statistical tests.
Participant confidentiality will be maintained throughout the study. All collected data will be anonymized and used exclusively for research purposes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive root canal obturation using CeraSeal Bioceramic Sealer. The sealer will be applied with a matching-taper gutta-percha cone using the single-cone technique after standard canal preparation and irrigation. The cavity will be sealed with glass ionomer cement. Postoperative pain will be recorded by participants using a Visual Analog Scale (VAS) at 12, 24, 48, and 72 hours.
Participants will receive root canal obturation using Sealapex Calcium Hydroxide Sealer applied with a matching-taper gutta-percha cone using the single-cone technique after standard canal preparation and irrigation. Cavities will be sealed with glass ionomer cement. Postoperative pain will be recorded by participants using the VAS at 12, 24, 48, and 72 hours.
Time frame: 12, 24, 48, and 72 hours after root canal obturation
Postoperative pain will be measured at 12, 24, 48, and 72 hours following root canal obturation. Pain intensity will be assessed using a Visual Analog Scale (VAS), where 0 represents "no pain," 1-3 indicates mild pain, 4-6 moderate pain, and 7-10 severe pain. Patients will record their pain scores at each time point, and any use of analgesics will also be documented to ensure accurate assessment.
Contact information is provided by the study sponsor or research team.
Beenish Qureshi, BDS, FCPS
CONTACT
Monal Fatima, BDS
CONTACT
HITEC-Institute of Medical Sciences
Other
Assessment of Postoperative Pain in Patients Obturated With Bioceramic and Calcium Hydroxide Sealers: A Randomized Clinical Trial
Acronym: BCvsCaOH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06640231
Neurologic Manifestations, Pain
Cairo, New Cairo, Egypt
View Trial DetailsNCT06525844
Symptomatic Irreversible Pulpitis
Islamabad, ICT, Pakistan
View Trial DetailsNCT07290049
Neurologic Manifestations, Pain
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT06298383
Symptomatic Irreversible Pulpitis
Cairo, Cairo Governorate, Egypt
View Trial Details